drugset / Trial / NCT01444651

A Trial of Tadalafil and Glycemic Traits

NCT01444651

Phase 3 Completed 73 enrolled Thomas J. Wang, MD
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to find out if tadalafil can help overweight and obese people metabolize blood sugar more efficiently. The investigators also want to find out if 20 mg/day of tadalafil for 3 months is safe to take without causing too many side effects. The investigators are plan to enroll 100 subjects at Massachusetts General Hospital (MGH).

Timeline

Start
2011-08
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral